checkAd
    Startseite > Aktien > Ovid Therapeutics > Nachrichten
    Ovid Therapeutics Aktie
    2,8400
     
    EUR
    -0,70 %
    -0,0200 EUR
    Letzter Kurs 03.05.24 Tradegate
    2,7600
     
    EUR
    909 STK
    Geldkurs 03.05.24
    2,9200
     
    EUR
    853 STK
    Briefkurs 03.05.24
    ISIN: US6904691010 · WKN: A2DQ8S · SYM: 1OT · USA

    Neueste Nachrichten

    Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
    04.04.24 · globenewswire · Ovid Therapeutics
    Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
    08.03.24 · globenewswire · Ovid Therapeutics
    Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
    28.02.24 · globenewswire · Ovid Therapeutics
    Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
    06.02.24 · globenewswire · Ovid Therapeutics
    Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates
    03.11.23 · globenewswire · Ovid Therapeutics
    Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid’s Cash Runway into 2026
    18.10.23 · globenewswire · Ovid Therapeutics
    Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit
    10.10.23 · globenewswire · Ovid Therapeutics
    Ovid Therapeutics to Host Investor Event - R&D Day on Monday, October 2, 2023
    26.09.23 · globenewswire · Ovid Therapeutics
    Ovid Therapeutics to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
    20.09.23 · globenewswire · Ovid Therapeutics
    Ovid Therapeutics to Participate in Upcoming September Investor Conferences
    30.08.23 · globenewswire · Ovid Therapeutics
    Ovid Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Updates
    04.08.23 · globenewswire · Ovid Therapeutics
    Ovid Therapeutics to Present at the BTIG Virtual Biotechnology Conference 2023
    01.08.23 · globenewswire · Ovid Therapeutics